CD196 (CCR6) Monoclonal Antibody (R6H1), eBioscience™, Invitrogen™

Description

• Description: This R6H1 monoclonal antibody reacts with CD196 (also known as CCR6), a seven transmembrane G protein-coupled receptor expressed on T, B, dendritic, natural killer, and Langerhans cells
• This CC chemokine receptor uniquely binds MIP-3a/CCL20, a chemoattractant for dendritic cells, effector/memory T cells, and B cells
• CD196 is also involved in host defense and inflammation at epithelial sites
• Furthermore, this receptor has been implicated in Th17 differentiation and CD4+FoxP3+ regulatory T cell development
• Applications Reported: This R6H1 antibody has been reported for use in flow cytometric analysis, immunoblotting (WB), and immunoprecipitation
• Applications Tested: This R6H1 antibody has been tested by western blot on lysates prepared from normal human peripheral blood cells
• This antibody can be used at less than or equal to 5 μg/mL
• Purity: Greater than 90%, as determined by SDS-PAGE
• Aggregation: Less than 10%, as determined by HPLC
• Filtration: 0.2 μm post-manufacturing filtered
• CCR6 is a member of the beta chemokine receptor family, which is predicted to be a seven transmembrane protein similar to G protein-coupled receptors
• The gene is preferentially expressed by immature dendritic cells and memory T cells
• The ligand of this receptor is macrophage inflammatory protein 3 alpha (MIP-3 alpha)
• This receptor has been shown to be important for B-lineage maturation and antigen-driven B-cell differentiation, and it may regulate the migration and recruitment of dentritic and T cells during inflammatory and immunological responses
• Alternatively spliced transcript variants that encode the same protein have been described for this gene.